NEU 3.98% $20.65 neuren pharmaceuticals limited

Ann: Q2 2023 quarterly activity and cash flow report, page-8

  1. 1,381 Posts.
    lightbulb Created with Sketch. 284
    It’s no longer in any indication. The four indications that we have under trial were excluded in the recent negotiations.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.